Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Roche and Prothena will Advance Prasinezumab into Late-Stage Clinical Development Study in Parkinson’s Disease
Wednesday, October 21, 2020Prothena Corporation plc a latestage clinical company with expertise in protein dysregulation and a diverse pipeline of investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases announced that based on positive signals o...
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
Wednesday, October 21, 2020Cytocom Inc Cytocom a leading biopharmaceutical company in the area of immunemodulation and Cleveland BioLabs Inc an innovative biopharmaceutical company developing novel approaches to activate the immune system today announced that they have entered...
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
Tuesday, October 20, 2020Genesis Therapeutics a privatelyheld company inventing and deploying stateoftheart artificial intelligence AI techniques to augment drug discovery and development today announced that it has entered into a multitarget collaboration agreement with Gen...
NGM Expands Oncology Portfolio with First Immuno-Oncology Development Candidate, NGM707, a Novel Dual Antagonist Antibody Inhibiting ILT2 and ILT4
Tuesday, October 20, 2020ORIC Pharmaceuticals Inc a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance today announced it has entered into an exclusive license agreement with Voronoi Inc an innovative drug disco...
Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment
Monday, October 19, 2020Akron Biotechnology today announced it has signed an agreement with Synairgen plc LSE SNG for the provision of SNG Synairgens whollyowned inhaled interferon beta IFNbeta therapeutic candidate for the treatment of COVID patients Akron Biotech provides...
Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Saturday, October 17, 2020Orchard Therapeutics a global gene therapy leader announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending full or standard marketing authorization for Lib...
Lilly Announces Agreement to Acquire Disarm Therapeutics
Friday, October 16, 2020Eli Lilly and Company announced a definitive agreement to acquire Disarm Therapeutics a privatelyheld biotechnology company creating a new class of diseasemodifying therapeutics for patients with axonal degeneration
Allogene Therapeutics and MD Anderson Announce Strategic Collaboration to Accelerate Advancement of Allogeneic CAR T Therapy (AlloCAR T™)
Friday, October 16, 2020Allogene Therapeutics Inc a clinicalstage biotechnology company pioneering the development of allogeneic CAR T therapies for cancer and The University of Texas MD Anderson Cancer Center today announced a strategic fiveyear collaboration agreement for...
Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic
Thursday, October 15, 2020Boehringer Ingelheim and Oxford BioTherapeutics Ltdannounced they are building on their successful partnership and are establishing a new alliance to discover additional selective targets for strategic cancer indications to deliver firstinclass treat...
Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
Thursday, October 15, 2020Dyno Therapeutics a biotech company applying artificial intelligence AI to gene therapy announced a collaboration and license agreement with Roche to apply Dynos CapsidMap platform for the development of nextgeneration adenoassociated virus AAV vecto...
